136 related articles for article (PubMed ID: 30405823)
1. Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.
Bhavsar SP; Løkke C; Flægstad T; Einvik C
Oncol Lett; 2018 Nov; 16(5):6786-6794. PubMed ID: 30405823
[TBL] [Abstract][Full Text] [Related]
2. Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells.
Bhavsar SP; Olsen L; Løkke C; Koster J; Flægstad T; Einvik C
Front Pediatr; 2023; 11():1098999. PubMed ID: 37033189
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of miR-376c-3p alleviates oxygen-glucose deprivation-induced cell injury by targeting ING5.
Zhang H; Zhou J; Zhang M; Yi Y; He B
Cell Mol Biol Lett; 2019; 24():67. PubMed ID: 31844418
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1.
Liu Y; Xu X; Xu X; Li S; Liang Z; Hu Z; Wu J; Zhu Y; Jin X; Wang X; Lin Y; Chen H; Mao Y; Luo J; Zheng X; Xie L
Oncol Lett; 2017 Nov; 14(5):5121-5128. PubMed ID: 29142597
[TBL] [Abstract][Full Text] [Related]
5. A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes.
Dai X; Huang R; Hu S; Zhou Y; Sun X; Gui P; Yu Z; Zhou P
Cell Biosci; 2020; 10():24. PubMed ID: 32128112
[TBL] [Abstract][Full Text] [Related]
6. miR-376c-3p modulates the properties of breast cancer stem cells by targeting RAB2A.
Zhao F; Zhong M; Pei W; Tian B; Cai Y
Exp Ther Med; 2020 Nov; 20(5):68. PubMed ID: 32963598
[TBL] [Abstract][Full Text] [Related]
7. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
Wang K; Jin J; Ma T; Zhai H
Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-LINC00152 down-regulated by miR-376c-3p restricts viability and promotes apoptosis of colorectal cancer cells.
Zhang YH; Fu J; Zhang ZJ; Ge CC; Yi Y
Am J Transl Res; 2016; 8(12):5286-5297. PubMed ID: 28078002
[TBL] [Abstract][Full Text] [Related]
9. microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway.
Cao X; Zhang J; Apaer S; Yao G; Li T
Int J Gen Med; 2021; 14():89-102. PubMed ID: 33469348
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of
Roth SA; Hald ØH; Fuchs S; Løkke C; Mikkola I; Flægstad T; Schulte J; Einvik C
Oncotarget; 2018 Apr; 9(26):18160-18179. PubMed ID: 29719597
[TBL] [Abstract][Full Text] [Related]
11. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.
Zehavi L; Avraham R; Barzilai A; Bar-Ilan D; Navon R; Sidi Y; Avni D; Leibowitz-Amit R
Mol Cancer; 2012 Jul; 11():44. PubMed ID: 22747855
[TBL] [Abstract][Full Text] [Related]
12. MiR-376c-3p targets heparin-binding EGF-like growth factor (HBEGF) to inhibit proliferation and invasion in medullary thyroid carcinoma cells.
Bai N; Hou D; Mao C; Cheng L; Li N; Mao X
Arch Med Sci; 2020; 16(4):878-887. PubMed ID: 32542091
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-219a-2-3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway.
Yang C; Zhang S; Chang X; Huang Y; Cui D; Liu Z
Exp Ther Med; 2021 Jun; 21(6):659. PubMed ID: 33968189
[TBL] [Abstract][Full Text] [Related]
14. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
[TBL] [Abstract][Full Text] [Related]
15. miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma.
Holliday H; Yang J; Dodson E; Nikolic I; Kamili A; Wheatley M; Deng N; Alexandrou S; Davis TP; Kavallaris M; Caldon CE; McCarroll J; De Preter K; Mestdagh P; Marshall GM; Simpson KJ; Fletcher J; Swarbrick A
Mol Ther; 2022 Mar; 30(3):1119-1134. PubMed ID: 34998954
[TBL] [Abstract][Full Text] [Related]
16. Differential Expression of MicroRNAs in Leprosy Skin Lesions.
Soares CT; Trombone APF; Fachin LRV; Rosa PS; Ghidella CC; Ramalho RF; Pinilla MG; Carvalho AF; Carrara DN; Soares FA; Belone AFF
Front Immunol; 2017; 8():1035. PubMed ID: 28970833
[TBL] [Abstract][Full Text] [Related]
17. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin.
Althoff K; Lindner S; Odersky A; Mestdagh P; Beckers A; Karczewski S; Molenaar JJ; Bohrer A; Knauer S; Speleman F; Epple M; Kozlova D; Yoon S; Baek K; Vandesompele J; Eggert A; Schramm A; Schulte JH
Int J Cancer; 2015 Mar; 136(6):1308-20. PubMed ID: 25046253
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
[TBL] [Abstract][Full Text] [Related]
20. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
